Eve Desmedt
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Tele-expertise reduces time to diagnosis for cutaneous melanoma.
Journal: Melanoma research
Published: November 01, 2025
Anti-EGFR plus anti-PD1 in advanced and refractory cutaneous squamous cell carcinoma: a cohort study.
Journal: The oncologist
Published: September 10, 2025
Life-threatening immune-related adverse events in the intensive care unit: a narrative review.
Journal: Intensive care medicine
Published: July 06, 2025
Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of age.
Journal: The oncologist
Published: July 04, 2025
Antigen vaccines in melanoma: Towards a new therapeutic paradigm
Journal: Bulletin du cancer
Published: October 24, 2024
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma.
Journal: Melanoma research
Published: March 15, 2024
Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma.
Journal: Clinical and experimental dermatology
Published: November 12, 2023
Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab.
Journal: Therapeutic advances in medical oncology
Published: November 02, 2020
Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit.
Journal: Journal of the American Academy of Dermatology
Published: January 15, 2019
Reprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)
Journal: Bulletin du cancer
Published: October 31, 2018
Last Updated: 09/26/2026